Immune Checkpoint Inhibitors: Altering the Landscape of Treatment in Hepatobiliary Cancers

In this interactive recording of a live CCO webinar, experts discuss current best practices and emerging strategies for using immune checkpoint inhibitors to treat patients with hepatobiliary cancers.

Lipika Goyal, MD R. Kate Kelley, MD Amit G. Singal, MD, MS Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: July 27, 2021 Expired: July 26, 2022

Download this slideset for expert perspectives on best practices and emerging strategies in using immune checkpoint inhibitors for patients with advanced hepatocellular carcinoma.

Lipika Goyal, MD R. Kate Kelley, MD Amit G. Singal, MD, MS Released: June 17, 2021

Download this slideset for expert perspectives on emerging strategies in using immune checkpoint inhibitors for patients with early- and intermediate-stage hepatocellular carcinoma and advanced biliary tract cancers.

Lipika Goyal, MD R. Kate Kelley, MD Amit G. Singal, MD, MS Released: June 17, 2021

Download this short summary slideset of key takeaway points on using immune checkpoint inhibitors for patients with hepatocellular carcinoma and biliary tract cancers.

Lipika Goyal, MD R. Kate Kelley, MD Amit G. Singal, MD, MS Released: June 18, 2021